Literature DB >> 25972476

Cutting edge: c-Kit signaling differentially regulates type 2 innate lymphoid cell accumulation and susceptibility to central nervous system demyelination in male and female SJL mice.

Abigail E Russi1, Margaret E Walker-Caulfield2, Mark E Ebel1, Melissa A Brown3.   

Abstract

Multiple sclerosis preferentially affects women, and this sexual dimorphism is recapitulated in the SJL mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). In this study, we demonstrate that signaling through c-Kit exerts distinct effects on EAE susceptibility in male and female SJL mice. Previous studies in females show that Kit mutant (W/W(v)) mice are less susceptible to EAE than are wild-type mice. However, male W/W(v) mice exhibit exacerbated disease, a phenotype independent of mast cells and corresponding to a shift from a Th2- to a Th17-dominated T cell response. We demonstrate a previously undescribed deficit in c-Kit(+) type 2 innate lymphoid cells (ILC2s) in W/W(v) mice. ILC2s are also significantly reduced in EAE-susceptible wild-type females, indicating that both c-Kit signals and undefined male-specific factors are required for ILC2 function. We propose that deficiencies in Th2-promoting ILC2s remove an attenuating influence on the encephalitogenic T cell response and therefore increases disease susceptibility.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25972476      PMCID: PMC4458435          DOI: 10.4049/jimmunol.1500068

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis.

Authors:  Blayne A Sayed; Margaret E Walker; Melissa A Brown
Journal:  J Immunol       Date:  2011-02-16       Impact factor: 5.422

2.  Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.

Authors:  Alison L Christy; Margaret E Walker; Martin J Hessner; Melissa A Brown
Journal:  J Autoimmun       Date:  2012-12-23       Impact factor: 7.094

Review 3.  IL-33/ST2 axis in inflammation and immunopathology.

Authors:  Marija Milovanovic; Vladislav Volarevic; Gordana Radosavljevic; Ivan Jovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

4.  IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Mingcai Li; Yan Li; Xiaojin Liu; Xueming Gao; Yaqing Wang
Journal:  J Neuroimmunol       Date:  2012-04-18       Impact factor: 3.478

5.  Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis.

Authors:  B F Bebo; E Zelinka-Vincent; G Adamus; D Amundson; A A Vandenbark; H Offner
Journal:  J Neuroimmunol       Date:  1998-04-15       Impact factor: 3.478

6.  Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro.

Authors:  Steffen Massa; Gina Balciunaite; Rhodri Ceredig; Antonius G Rolink
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

7.  IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

Authors:  Hui-Rong Jiang; Marija Milovanović; Debbie Allan; Wanda Niedbala; Anne-Galle Besnard; Sandra Y Fukada; Jose C Alves-Filho; Dieudonnée Togbe; Carl S Goodyear; Christopher Linington; Damo Xu; Miodrag L Lukic; Foo Y Liew
Journal:  Eur J Immunol       Date:  2012-06-12       Impact factor: 5.532

8.  Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.

Authors:  Marija Milovanovic; Vladislav Volarevic; Biljana Ljujic; Gordana Radosavljevic; Ivan Jovanovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  Transcription factor RORα is critical for nuocyte development.

Authors:  See Heng Wong; Jennifer A Walker; Helen E Jolin; Lesley F Drynan; Emily Hams; Ana Camelo; Jillian L Barlow; Daniel R Neill; Veera Panova; Ute Koch; Freddy Radtke; Clare S Hardman; You Yi Hwang; Padraic G Fallon; Andrew N J McKenzie
Journal:  Nat Immunol       Date:  2012-01-22       Impact factor: 25.606

Review 10.  Innate lymphoid cells--a proposal for uniform nomenclature.

Authors:  Hergen Spits; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gerard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

View more
  23 in total

Review 1.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Authors:  Medya M Shikhagaie; Kristine Germar; Suzanne M Bal; Xavier Romero Ros; Hergen Spits
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

2.  IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus.

Authors:  Kathleen Bartemes; Chien-Chang Chen; Koji Iijima; Li Drake; Hirohito Kita
Journal:  J Immunol       Date:  2017-11-13       Impact factor: 5.422

Review 3.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

Review 4.  Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.

Authors:  Tingting Xiong; Jan-Eric Turner
Journal:  Semin Immunopathol       Date:  2018-03-22       Impact factor: 9.623

Review 5.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 6.  Interaction Between Innate Lymphoid Cells and the Nervous System.

Authors:  Yuanyue Zhang; Rachel Grazda; Qi Yang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Coordination of Mucosal Immunity by Innate Lymphoid Cells.

Authors:  Jordan Z Zhou; Gregory F Sonnenberg
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 8.  The spectrum of sex differences in cancer.

Authors:  Joshua B Rubin
Journal:  Trends Cancer       Date:  2022-02-18

9.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.

Authors:  Abigail E Russi; Mark E Ebel; Yuchen Yang; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

Review 10.  Group 2 innate lymphoid cells in disease.

Authors:  Timotheus Y F Halim
Journal:  Int Immunol       Date:  2015-08-25       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.